US Broker Ratings

Encompass Health Corporation (EHC) Stock Analysis: Exploring a 17% Potential Upside with Strong Buy Ratings

Encompass Health Corporation (NYSE: EHC) is capturing the attention of investors with its robust market position in the healthcare sector, specifically within the medical care facilities industry. With a market..

Eli Lilly (LLY) Stock Analysis: 9% Upside Potential Amid Robust Revenue Growth

Eli Lilly and Company (NYSE: LLY) continues to capture the attention of investors, particularly with its impressive market capitalization of $1.06 trillion, placing it firmly among the giants in the..

Universal Health Services, Inc. (UHS) Stock Analysis: Navigating a 11.48% Upside Potential Amid Healthcare Growth

As investors continue to explore opportunities in the healthcare sector, Universal Health Services, Inc. (NYSE: UHS) stands out with a compelling combination of growth potential and strategic positioning. With a..

Cencora, Inc. (COR) Stock Analysis: Healthcare Distribution Giant with a 14.60% Upside Potential

Cencora, Inc. (COR), a stalwart in the healthcare sector specializing in medical distribution, presents an intriguing opportunity for investors seeking both stability and growth potential. With a market capitalization of..

GSK plc (GSK) Stock Analysis: Exploring a 9.66% Potential Upside in the Healthcare Giant

GSK plc (NYSE: GSK), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and promising outlook. As of the latest trading data, GSK..

Boston Scientific Corporation (BSX) Stock Analysis: Is a 27% Upside on the Horizon?

Boston Scientific Corporation (NYSE: BSX), a leading player in the healthcare sector, particularly in the medical devices industry, has piqued investor interest with its robust market presence and promising growth..

Novo Nordisk A/S (NVO) Stock Analysis: Navigating Growth and Stability with a 59.82% ROE

Novo Nordisk A/S (NVO), a titan in the healthcare sector, commands a formidable presence in the drug manufacturing industry with a market capitalization of $208.92 billion. Headquartered in Bagsvaerd, Denmark,..

Mettler-Toledo International, Inc. (MTD) Stock Analysis: Navigating Growth in the Diagnostics & Research Sphere

Mettler-Toledo International, Inc. (NYSE: MTD) has established itself as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Greifensee, Switzerland, the company boasts..

Royalty Pharma plc (RPRX) Stock Analysis: Navigating a 12.30% Upside Potential in the Biotech Arena

Royalty Pharma plc (NASDAQ: RPRX) stands out in the healthcare sector, specifically within the biotechnology industry, as a unique player that capitalizes on biopharmaceutical royalties. This strategic positioning not only..

Regeneron Pharmaceuticals, Inc. (REGN) Stock Analysis: Navigating Biotech Opportunities with a 6.27% Upside Potential

Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is a heavyweight in the biotechnology sector, boasting a market cap of $80.75 billion. With its headquarters in Tarrytown, New York, Regeneron is a leader..

Pfizer, Inc. (PFE) Stock Analysis: A Robust Dividend Yield Amidst Healthcare Sector Challenges

Pfizer Inc. (NYSE: PFE), a titan in the healthcare sector, continues to captivate investors with its robust dividend yield of 6.43%, positioning itself as an attractive option for income-focused investors...

AbbVie Inc. (ABBV) Stock Analysis: Evaluating Growth Potential with a 11.51% Upside

AbbVie Inc. (NYSE: ABBV) stands out in the healthcare sector as an influential player in the drug manufacturing industry. Headquartered in North Chicago, Illinois, the biopharmaceutical company has established a..

UnitedHealth Group (UNH) Stock Analysis: Navigating 16.74% Potential Upside Amid Solid Dividend Yield

UnitedHealth Group Incorporated (NYSE: UNH), a stalwart in the healthcare sector, continues to capture investor attention with its robust market presence and diversified offerings through its four main segments: Optum..

Novartis AG (NVS) Stock Analysis: Evaluating Growth Prospects Amidst Strong Dividend Yield

Novartis AG (NYSE: NVS), a giant in the healthcare sector based in Switzerland, is a prominent player in the general drug manufacturing industry. With a substantial market capitalization of $297.14..

Sanofi (SNY) Stock Analysis: Healthcare Giant Offers 24.38% Potential Upside with Strong Dividend Yield

Sanofi (NASDAQ: SNY), a prominent player in the healthcare sector, has been a staple in many portfolios, especially for those eyeing the drug manufacturing industry. Headquartered in Paris, France, Sanofi’s..

CVS Health Corporation (CVS) Stock Analysis: 21% Upside Potential Amid Robust Dividend Yield

CVS Health Corporation (NYSE: CVS) has long been a stalwart in the healthcare sector, continually adapting its multifaceted business model to meet the complex demands of the U.S. healthcare landscape...

Centene Corporation (CNC) Stock Analysis: Is Its 8.97% Potential Upside Worth the Investment?

In the dynamic landscape of healthcare, Centene Corporation (NYSE: CNC) stands out as a prominent player in the managed care industry. With a market capitalization of $32.49 billion, Centene operates..

McKesson Corporation (MCK) Stock Analysis: Evaluating the 13% Upside Potential for Investors

McKesson Corporation (NYSE: MCK), a stalwart in the healthcare sector, is commanding attention with a market cap exceeding $101 billion. As a leader in medical distribution, McKesson plays a pivotal..

IDEXX Laboratories (IDXX) Stock Analysis: Navigating a 20% Potential Upside in the Diagnostics Sector

IDEXX Laboratories, Inc. (NASDAQ: IDXX) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. With a substantial market capitalization of $46.28 billion, this..

Elevance Health, Inc. (ELV) Stock Analysis: Exploring a 13.93% Potential Upside for Investors

Elevance Health, Inc. (NYSE: ELV), a prominent player in the healthcare sector, is capturing investor attention with its robust market position and the enticing potential upside of nearly 14%. Known..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds